HPV vaccine (Gardasil/Cervarix) Orthomolecular Treatment Protocol


Severity of side effects

When other health experts re-evaluated those cases, they determined 1,112 (44%) to be serious. The initial onset of symptoms occurred several weeks to a year after the HPV vaccine was given. They included: headache, dizziness, muscle weakness and pain, nausea, hypersomnia, learning difficulty, impaired writing, photophobia, tremors of arms, feet and fingers, joint pain, irregular menstruation, gait disturbance, memory loss, skin eczema and acne.

Girls who had adverse effects from the HPV vaccine were variously diagnosed with:

  1. Higher brain dysfunction
  2. Guillain-Barré syndrome
  3. Multiple sclerosis
  4. ADEM: acute disseminated encephalomyelitis
  5. SSPE: subacute sclerosing panencephalitis
  6. CRPS: Complex regional pain syndrome
  7. POTS: Postural orthostatic tachycardia syndrome
  8. Anti-phospholipid antibody syndrome
  9. SLE: systemic lupus erythematosus
  10. Rheumatoid arthritis
  11. Chronic fatigue syndrome
  12. Fibromyalgia
  13. Cushing’s syndrome (exposure to high level of cortisol)
  14. Hashimoto’s disease (immune system attacks the thyroid)
  15. Hyperprolactinemia (high prolactin, induces breast development and lactation)

Laboratory findings included:

  1. Normal blood chemistry
  2. No inflammatory finding in the blood
  3. Increased pro-inflammatory cytokines in the spinal fluid (IL-2, IL-10, TNF-à)
  4. Reduced brain blood flow by perfusion scintigraphy
  5. High leukocyte sensitivity against aluminum.


HPV vaccine contains toxic aluminum

Vaccines often contain an adjuvant, which is an additional chemical added to provoke the body’s immune response to the vaccine. The HPV vaccines contained an adjuvant that consisted of an aluminum compound, amorphous aluminum hydroxyphosphate sulfate (AAHS).

Current research strongly implicates aluminum adjuvants in various inflammatory neurological and autoimmune disorders in both humans and animals. For example, a recent research paper explained that nanomaterials such as this aluminum adjuvant can be transported by immune system cells first into the blood, lymph nodes, and spleen, and in some cases may penetrate into the brain. [1] This type of access throughout the body is potentially life-threatening. The brain symptoms are often the most delayed because of the time the aluminum takes to travel from the blood through the blood-brain-barrier into the brain.

Aluminum accumulates in neurons in the brain, and it is toxic to neurons, causing a variety of pathological conditions. It inhibits uptake of dopamine and serotonin, which are important neurotransmitters in the brain. Aluminum toxicity is a known factor in Alzheimer’s disease, and may contribute symptoms of Parkinson’s disease. Dementia resulting from kidney dialysis is related to aluminum and results in memory loss, loss of coordination, confusion and disorientation. In animal experiments, rabbits given aluminum showed difficulty in memory retention and difficulty in learning.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.